By Rafael R. Castillo, MD

Despite therapeutic and public health advances, cardiovascular disease (CVD) remains the top cause of mortality in the Philippines. Ischemic heart disease and stroke have consistently led annual mortality tables through 2023–2024, according to official statistics. This sustained dominance is not a mere statistical artifact; rather, it reflects persistent, high-level population risk exposure coupled with systemic weaknesses in prevention, early detection, and chronic disease control.

The Persistent Burden: High Risk Exposure and Inadequate Control (Uncontrolled Population-Level Risk Exposure)

Risk factor prevalence remains alarmingly high, driving the CVD epidemic:

• High Sodium Intake: Daily sodium intake among Filipino adults averages approximately 4.1 grams of sodium (or about 10 grams of salt), which is more than double the World Health Organization’s (WHO) recommended maximum of less than 2 grams of sodium per day. This level of intake is a primary driver of prevalent hypertension and stroke risk.
• Physical Inactivity Crisis: Physical inactivity is a profound challenge, particularly among youth. Over 80% of adolescents fail to meet recommended physical activity guidelines, with Filipino boys noted as among the least active globally. This crisis ensures a continuous supply of future CVD cases.
• Tobacco Use: While consumption has declined following the implementation of the “Sin Tax” reforms, roughly 1 in 5 adults still used tobacco in 2021, with prevalence rates significantly higher among men.
• Metabolic Risk Trends: National nutrition surveys indicate that dyslipidemia and obesity have continued to trend upward, further compounding overall cardiovascular risk.

Inadequate Detection and Control of Hypertension and Dyslipidemia

National health surveys and community screening campaigns reveal substantial gaps in the awareness, treatment, and control of key risk factors.

• Hypertension Control: While some data suggest that hypertension prevalence has recently leveled, control among treated patients remains modest. In one nationwide opportunistic screening program, fewer than half of treated hypertensive individuals achieved target blood pressure (BP) goals.
• Primary Care Gaps: Similarly, lipid screening and appropriate statin use are inconsistent across primary care settings.

System Weaknesses: Underpowered Primary Care and the Food Environment

The Primary Care Implementation Gap

The 2019 Universal Health Care (UHC) Act strategically placed primary care at the center of the health system. However, the implementation of this policy has been uneven. The Philippine Health Insurance Corporation’s (PhilHealth) Konsulta package offers financing for essential services (consultations, basic labs like fasting glucose and lipids, ECGs, and selected medicines). If fully realized, these benefits could significantly alter CVD trajectories. The core gap is not the policy itself, but rather the rapid, high-fidelity rollout of service delivery, expansion of provider networks, and the consistent measurement of patient outcomes.

A Food Environment Favoring CVD

While the Philippines deserves commendation for its decisive policy eliminating industrial trans fatty acids through Department of Health (DOH) and Food and Drug Administration (FDA) regulations, comprehensive sodium reduction policies and large-scale food reformulation programs are still in the early stages. Clear, population-wide salt reduction strategies and effective front-of-pack labeling nudges remain limited.

A National Game Plan: Defined Roles for Bending the CVD Curve

Closing the gap requires a synchronized, multi-sectoral approach with clearly defined responsibilities for key actors.

1. Government: Lock in Prevention as the Default

The government must solidify prevention and early detection through decisive policy and financing reforms:

• Finish the Primary Care Pivot: Scale the Konsulta model to ensure every Filipino is empaneled to a specific primary care provider (PCP), public or private. This empanelment must include automatic annual CVD risk screening (BP, BMI/waist, lipids, smoking status, and fasting glucose or HbA1c for those at risk). Provider payments should be tied to measurable outcomes, such as the proportion of patients with controlled BP (e.g., mmHg), appropriate statin use among high-risk adults, and documented smoking quit rates. Public league tables by province should be published to spur localized performance improvement.
• Guarantee the “Vital Few” Medicines and Labs: Ensure continuous availability and no-cost (or nominal copay) access to a tight, high-value essential formulary: thiazide-like diuretics, ACE inhibitors/ARBs, calcium-channel blockers, high-intensity statins, metformin, SGLT2 inhibitors for eligible high-risk patients, and aspirin for secondary prevention. This formulary must be paired with covered, essential tests: lipids, HbA1c, creatinine/eGFR, and ECG. The challenge is not listing these items (many are already in PhilHealth circulars), but overcoming last-mile supply chain failures and ensuring adherence support.
• Make Salt Reduction a National Mission: The Philippines should immediately adopt the WHO’s “best-buy” sodium policies: (1) mandatory, stepwise sodium targets for key food categories (e.g., instant noodles, canned meats, sauces/condiments); (2) national mass-media campaigns; (3) standardized, prominent front-of-pack warning labels; and (4) procurement standards for schools, hospitals, and government canteens [4]. Given current average intake, this is the single most powerful dietary lever for reducing population BP and stroke incidence.
• Double Down on Tobacco Taxation and Cessation: Sustain real-term (inflation-plus-income) increases in excise taxes on tobacco products, close existing loopholes, and legally earmark a defined portion of revenues to finance UHC and cessation services. Expand free quitlines and integrate brief-advice protocols into primary care; measure and reward quit-rate outcomes. The Sin Tax has proven effective in cutting consumption and raising health financing; the objective now is to drive adult prevalence down by an additional 5–10 percentage points.
• Build Active Cities: Fund Local Government Unit (LGU)-level “MovePH” packages that invest in protected walking and cycling infrastructure, mandate daily physical education (PE) in schools, support open-street weekends, and pilot physical-activity prescription programs within Konsulta clinics. Addressing the current adolescent inactivity crisis is crucial to preventing the next wave of CVD.

2. Professional Organizations: Standardize and Scale Control

Societies like the Philippine Heart Association and the Philippine Society of Hypertension must drive clinical standardization:

• One National BP and Lipid Protocol: Publish a unified, simplified clinical algorithm (e.g., A, B, C, D choices; fixed-dose combinations preferred) that is harmonized with UHC benefits and the essential medicines list. This algorithm should be embedded in electronic medical records and patient chart prompts. While community screening (like May Measurement Month, MMM) is valuable for identification, the focus must shift to patient retention and control within the formal health system.
• Train for Task-Sharing: Develop competency-based training programs that enable nurses, midwives, and pharmacists to titrate medications under protocol, manage adherence clubs, and deliver structured brief advice on tobacco and salt reduction. Rapid, national scale-up of control requires moving treatment beyond specialized cardiology clinics.
• Make Control Rates the Key Performance Indicator (KPI): Shift Continuous Medical Education (CME) and hospital accreditation incentives toward primary-prevention metrics, specifically: the percentage of known hypertensives who achieve control, appropriate statin use in secondary prevention, and documented time-to-follow-up after an elevated BP reading. Annual scorecards by region should be published.

3. Civil Society and Media: Shape Norms and Watchdog Implementation

Non-governmental organizations (NGOs) and media must act as powerful agents for change:

• Social Marketing for Salt and Activity: Leverage the successful strategies used to build public support for the Sin Tax Law. This involves normalizing low-salt cooking (e.g., “Hapag na Mababang Asin” campaigns), promoting “daily 30” movement minutes, and framing heart health as a core family and faith value. Partnering with churches, cooperatives, and barangay health workers is essential for local diffusion.
• Independent Monitoring: Universities and NGOs can provide crucial independent oversight by tracking key metrics: sodium content in packaged foods (through laboratory testing against labels), retail cigarette prices (to detect potential tax avoidance), and PhilHealth Konsulta uptake and stockout rates. Public reporting of these data will maintain pressure for course correction.

4. Citizens: Small Habits, Big Population Effect

Every Filipino plays a role in shifting the risk curve:

• Know your numbers: Check BP at least twice a year after age 30 (more often if elevated), and have fasting glucose/HbA1c and lipids checked as advised by a PCP.
• Cut salt in half: Switch to low-sodium condiments, taste food before salting, and prioritize “low sodium” packaged options as the food industry reformulates.
• Move daily: Aim for minutes per week of moderate physical activity. Parents should actively advocate for daily PE in schools and safe walking/cycling infrastructure in their communities.
• Quit tobacco completely: Utilize the Konsulta provider for brief cessation advice and medication support if needed.

Governance: How to Make it Stick

Sustained success requires an accountability framework based on public data and outcome-based financing:

1. A National CVD Dashboard: The DOH, PhilHealth, Philippine Statistics Authority (PSA), and professional organizations should co-maintain a public dashboard tracking essential indicators: hypertension prevalence, treatment, and control; statin use in high-risk groups; acute MI and stroke case fatality; tobacco prevalence; sodium content in priority foods; and physical-activity indicators. A portion of LGU health grants should be tied to demonstrated improvement on these indicators.
2. Pay for Outcomes—At Scale: Move PhilHealth’s Konsulta capitation model toward a blended payment system that includes quality bonuses for achieving BP/lipid control and high quit rates. The Annex-listed labs and medicines are necessary inputs, but the ultimate reward should be tied to actual risk-factor control as the output.
3. Protect the Food Policy Wins: Vigorously enforce the industrial trans-fat ban (through market surveillance and penalties) and formalize mandatory sodium targets in national regulation. The successful trans-fat policy demonstrates the political will and technical capacity to enact bold nutrition regulations; sodium is the next critical target.
4. Sustain Sin Tax Momentum: Legislatively mandate regular inflation-plus increases in excise taxes, maintain minimum price floors, and implement strict anti-illicit trade measures. A defined, non-negotiable share of these revenues must be earmarked for UHC primary care and NCD prevention.

Bottom Line

The continued dominance of CVD on the mortality table should be and can be curbed. The Philippines has the foundational components in place: UHC legislation, the PhilHealth Konsulta benefits package, a successful trans-fat ban, and a track record of effective tobacco taxation. What is needed now is disciplined, high-fidelity execution focused on primary prevention, a decisive national sodium-reduction program, outcome-based financing, and a sustained social movement that makes the healthy choice the easy choice. If each major actor leans into the specific, defined roles outlined above, the country can successfully bend the CVD curve within a decade and finally dethrone heart disease and stroke from the top of the mortality table.

---